Yurasov Sergey 4

Accession 0001209191-18-043393

CIK 0001437786other

View on SEC.gov Company Profile

Filed

Jul 18, 8:00 PM ET

Accepted

Jul 19, 6:01 PM ET

Size

22.7 KB

Accession

0001209191-18-043393

Insider Transaction Report

Form 4

Period: 2018-07-17

IMMUNE DESIGN CORP.IMDZ

Yurasov Sergey

Sr. VP, Clinic. Devel. & CMO

Transactions

Award
Stock Option (Rt to Buy)
2018-07-17+417→ 417 total
Exercise: $4.40Exp: 2025-07-17→ Common Stock (417 underlying)
Award
Stock Option (Rt to Buy)
2018-07-17+35,179→ 35,179 total
Exercise: $4.40Exp: 2025-07-17→ Common Stock (35,179 underlying)
Disposition to Issuer
Stock Option (Rt to Buy)
2018-07-17−625→ 0 total
Exercise: $5.60Exp: 2027-01-04→ Common Stock (625 underlying)
Disposition to Issuer
Stock Option (Rt to Buy)
2018-07-17−29,375→ 0 total
Exercise: $5.60Exp: 2027-01-04→ Common Stock (29,375 underlying)
Award
Stock Option (Rt to Buy)
2018-07-17+19,584→ 19,584 total
Exercise: $4.40Exp: 2025-07-17→ Common Stock (19,584 underlying)
Disposition to Issuer
Stock Option (Rt to Buy)
2018-07-17−52,768→ 0 total
Exercise: $7.58Exp: 2025-10-01→ Common Stock (52,768 underlying)
Disposition to Issuer
Stock Option (Rt to Buy)
2018-07-17−87,232→ 0 total
Exercise: $7.58Exp: 2025-10-01→ Common Stock (87,232 underlying)
Award
Stock Option (Rt to Buy)
2018-07-17+58,155→ 58,155 total
Exercise: $4.40Exp: 2025-07-17→ Common Stock (58,155 underlying)

Footnotes (8)

[F1]The option provided for vesting of 1/4th of the shares underlying the option on October 1, 2017 and the remainder of the shares at a rate of 1/36th per month thereafter.
[F2]On July 17, 2018, the issuer canceled, pursuant to the issuer's option exchange program, an option for 52,768 shares of the issuer's common stock granted to the reporting person on October 1, 2016. In exchange, the reporting person received a replacement option, for 35,179 shares, having an exercise price of $4.40 per share.
[F3]The option vests in twenty four (24) equal consecutive monthly installments beginning on August 17, 2018.
[F4]On July 17, 2018, the issuer canceled, pursuant to the issuer's option exchange program, an option for 87,232 shares of the issuer's common stock granted to the reporting person on November 1, 2016. In exchange, the reporting person received a replacement option, for 58,155 shares, having an exercise price of $4.40 per share.
[F5]The option provided for 1/4th of the shares underlying the option on January 4, 2018 and the remainder of the shares underlying the option at a rate of 1/36th per month thereafter.
[F6]On July 17, 2018, the issuer canceled, pursuant to the issuer's option exchange program, an option for 625 shares of the issuer's common stock granted to the reporting person on January 4, 2017. In exchange, the reporting person received a replacement option, for 417 shares, having an exercise price of $4.40 per share.
[F7]The option vests in thirty six (36) equal consecutive monthly installments beginning on August 17, 2018.
[F8]On July 17, 2018, the issuer canceled, pursuant to the issuer's option exchange program, an option for 29,375 shares of the issuer's common stock granted to the reporting person on January 4, 2017. In exchange, the reporting person received a replacement option, for 19,584 shares, having an exercise price of $4.40 per share.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

IMMUNE DESIGN CORP.

CIK 0001437786

→

Entity typeother

Related Parties

filerCIK 0001686295

Filing Metadata

Form type: 4
Filed: Jul 18, 8:00 PM ET
Accepted: Jul 19, 6:01 PM ET
Size: 22.7 KB

View on SEC.gov